6.26 USD
-0.23
3.54%
Updated May 14, 2:06 PM EDT
1 day
-3.54%
5 days
4.86%
1 month
15.93%
3 months
-36.32%
6 months
-57.24%
Year to date
-47.57%
1 year
-52.18%
5 years
-80.25%
10 years
-61.85%
 

About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.

Employees: 1,315

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

39% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 33

34% more call options, than puts

Call options by funds: $1.6M | Put options by funds: $1.19M

11.19% more ownership

Funds ownership: 108.55% [Q3] → 119.74% (+11.19%) [Q4]

2% more funds holding

Funds holding: 334 [Q3] → 341 (+7) [Q4]

9% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 127

20% less capital invested

Capital invested by funds: $3.95B [Q3] → $3.15B (-$800M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 0 (-3) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$5
20%
downside
Avg. target
$9
44%
upside
High target
$13
108%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
Piper Sandler
David Westenberg
48% 1-year accuracy
15 / 31 met price target
20%downside
$5
Neutral
Maintained
22 Apr 2025
Guggenheim
Subbu Nambi
35% 1-year accuracy
8 / 23 met price target
108%upside
$13
Buy
Maintained
10 Apr 2025

Financial journalist opinion

Based on 4 articles about NEOG published over the past 30 days

Neutral
Business Wire
22 hours ago
Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that James P. Tobin has chosen to retire from the Company's Board of Directors, effective May 31, 2025. Mr. Tobin has served on Neogen's Board since 2016 and currently chairs the Governance and Sustainability Committee and serves on the Audit Committee. James C. Borel, Chair of the Neogen Board of Directors, will serve as the interim Chair of the Governance and Sus.
Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin
Positive
Zacks Investment Research
5 days ago
Why Is Neogen (NEOG) Up 6.4% Since Last Earnings Report?
Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?
Why Is Neogen (NEOG) Up 6.4% Since Last Earnings Report?
Neutral
Seeking Alpha
3 weeks ago
Neogen: A Fair Divestment (Rating Upgrade)
Neogen's merger with 3M Food Safety led to significant debt and operational struggles, causing shares to plummet and the CEO to be ousted. Following disappointing sales and earnings, the company is exploring asset sales and restructuring, offering potential upside if stabilization occurs. Neogen's current valuation appears modest relative to sales, presenting a speculative opportunity for investors willing to take on risk.
Neogen: A Fair Divestment (Rating Upgrade)
Neutral
Business Wire
3 weeks ago
Neogen Announces Sale of Cleaners & Disinfectants Business
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global cleaners and disinfectants business to Kersia Group (“Kersia”), a global leader in biosecurity, disinfection and hygiene solutions, for $130 million in cash at closing plus contingent consideration tied to the future performance of the business. The transaction is expected to be accretive to margins and c.
Neogen Announces Sale of Cleaners & Disinfectants Business
Negative
Zacks Investment Research
1 month ago
Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract
NEOG posts lower-than-expected earnings and revenues for the third quarter of fiscal 2025.
Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract
Neutral
Zacks Investment Research
1 month ago
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended February 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Negative
Benzinga
1 month ago
Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Wednesday.
Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results
Neutral
Seeking Alpha
1 month ago
Neogen Corporation (NEOG) Q3 2025 Earnings Call Transcript
Neogen Corporation (NASDAQ:NEOG ) Q3 2025 Earnings Conference Call April 9, 2025 8:00 AM ET Company Participants Bill Waelke - VP, IR John Adent - CEO and President David Naemura - CFO Conference Call Participants Brandon Vazquez - William Blair Subbu Nambi - Guggenheim Thomas DeBourcy - Nephron Research David Westenberg - Piper Sandler Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation Third Quarter Fiscal Year 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, April 9, 2025.
Neogen Corporation (NEOG) Q3 2025 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Neogen (NEOG) Lags Q3 Earnings and Revenue Estimates
Neogen (NEOG) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.12 per share a year ago.
Neogen (NEOG) Lags Q3 Earnings and Revenue Estimates
Negative
Investors Business Daily
1 month ago
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take direct aim at drug imports. The post Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports appeared first on Investor's Business Daily.
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Charts implemented using Lightweight Charts™